u/thyroid_tangent

pens and vials are the same molecule, the price is the difference

The 21% figure is a 72-week mean on the highest arm. Quoting it as what someone should expect by week 49 is not a fair reading.

Inter-lab variance on this assay runs roughly a point either way, driven mostly by gradient and integration. Two results inside that band agree; they do not disagree quietly.

What a result posted here is actually worth, and how to make yours worth more.

A single figure with no batch identifier is about a vial nobody can locate. Add the batch and it becomes about a lot. Add the claimed figure from the certificate and it becomes a comparison. Add the service and the date and it becomes reproducible. Say that you paid for it yourself and it becomes independent.

Five extra fields, thirty seconds of typing, and the difference between a comment and a row in the log that will still be useful in three years.

That comparison crosses two labs with different assays. The difference you are describing may be the method.

weight loss itself moves several of these independently

Area percent and net peptide content are different measurements and most reports give one. Quote which, or the comparison downstream is meaningless.

Weekly dosing again, half-life in the same neighbourhood as sema, so a step change takes about a month to reach steady state. Judging a new step at day five is judging noise.

Which service, and did you pay for it yourself?

Careful — that is a question for whoever ordered the panel, and nobody in this thread can answer it responsibly.

Adding the obvious one — take it to whoever ordered the panel. This board cannot read it for you.

Small fix: SURMOUNT is the obesity programme, SURPASS is the type-2 programme.

Saving this one. It is the clearest statement of the stall problem I have read here.

Small fix — same supplier, different lot. The two rows in the log are not the same batch.

Did the vial lot match the paperwork lot?

split a vial across two services once and you will never argue about ground truth again

zepbound and mounjaro are the same compound with different labels

Area percent and net peptide content are different measurements and most reports give one. Quote which, or the comparison downstream is meaningless.

On comparing yourself with the trial number.

SURMOUNT-1 reported roughly 21% mean body weight change at 72 weeks on the highest arm. Three things get dropped every time that figure is quoted here. It is a mean, and the distribution around it is very wide. It is 72 weeks, which is a year and a half. And it is a trial population with trial support, which is not the same as a person with a spreadsheet.

Use it as a rough shape, not a benchmark. A 12% year is inside the ordinary range and people quit over it every week on this board.

SURMOUNT-1 ran 72 weeks with the top arm around 21% mean body weight change. SURPASS is the diabetes programme and reports glycaemic endpoints, so quoting the two interchangeably is a category error.

Agreed — the template exists because a result without the batch and the claim is unanchored.

Same view — ApoB if you add one thing. It answers a question the standard panel only gestures at.

Agreed on assay changes. A lab switching platforms between your draws is invisible unless you ask.

Did you come to this from sema, and if so how long was the gap?

draw at the same point in the week if you want comparability

The step schedule question, answered properly, because it comes up weekly.

The label sets a minimum interval of four weeks between increases. That is a floor on how fast you may go, and it exists because tolerability, not efficacy, is what limits most people. There is nothing in the pharmacology that says you must increase at four weeks, or at eight, or ever.

What decides it in practice is whether the effect you want is still there. If appetite is quiet and the trend is going the right way, the dose is doing its job. If both have genuinely gone flat for six weeks or more, that is a conversation worth having with someone who knows your history.

Nobody here can interpret your panel and this comment is not doing so. What a board can usefully do is help you ask better questions of somebody who can.

Added ApoB to the panel after a thread here. It told me something the standard lipid panel had been hiding.

Careful — that reads as advice about what someone else should do, and this board is for describing your own.

Which service, and did you pay for it yourself?

Careful — that reads as advice about what someone else should do, and this board is for describing your own.

fasting state and time of day change more than people expect

A series across separate lots estimates a process. Repeat tests on one lot estimate the measurement. Both are useful and they answer different questions.

Disagree with the conversion table. There is no validated equivalence between the two molecules and posting one as though there is does real damage.

area percent unless the report says otherwise

nobody owes anybody a starting weight

Adding the thing I wish someone had said to me — the goal you picked at week one was a guess.

Weekly dosing again, half-life in the same neighbourhood as sema, so a step change takes about a month to reach steady state. Judging a new step at day five is judging noise.

What a result posted here is actually worth, and how to make yours worth more.

A single figure with no batch identifier is about a vial nobody can locate. Add the batch and it becomes about a lot. Add the claimed figure from the certificate and it becomes a comparison. Add the service and the date and it becomes reproducible. Say that you paid for it yourself and it becomes independent.

Five extra fields, thirty seconds of typing, and the difference between a comment and a row in the log that will still be useful in three years.

How many weeks between the two measurements?

Not sure that follows. You went up a step and changed your training in the same fortnight.

Same. The GL Biochem results have been sitting in a tight band across lots, which is the useful shape.

On the goal weight you set in week one.

You chose it with the least information you will ever have about how this feels, what is sustainable, and what your body does at different points. Revising it is not moving the goalposts; it is updating a prediction, which is what you are supposed to do with predictions.

Several of the longest-standing members here have revised theirs more than once, in both directions, and describe the revision as the point at which the whole thing became manageable. What the number should be is a conversation with somebody who knows your history — but that it is allowed to change is something this board can tell you.